The Lysine 65 Residue in HIV-1 Reverse Transcriptase Function and in Nucleoside Analog Drug Resistance
出版年份 2014 全文链接
标题
The Lysine 65 Residue in HIV-1 Reverse Transcriptase Function and in Nucleoside Analog Drug Resistance
作者
关键词
-
出版物
Viruses-Basel
Volume 6, Issue 10, Pages 4080-4094
出版商
MDPI AG
发表日期
2014-10-24
DOI
10.3390/v6104080
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- 4′-Ethynyl-2-fluoro-2′-deoxyadenosine (EFdA) Inhibits HIV-1 Reverse Transcriptase with Multiple Mechanisms
- (2014) Eleftherios Michailidis et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Identification of a rare mutation at reverse transcriptase Lys65 (K65E) in HIV-1-infected patients failing on nucleos(t)ide reverse transcriptase inhibitors
- (2013) Slim Fourati et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Hypersusceptibility mechanism of Tenofovir-resistant HIV to EFdA
- (2013) Eleftherios Michailidis et al. Retrovirology
- Lys66 residue as a determinant of high mismatch extension and misinsertion rates of HIV-1 reverse transcriptase
- (2012) Chisanga Lwatula et al. FEBS Journal
- Effects of the K65R and K65R/M184V reverse transcriptase mutations in subtype C HIV on enzyme function and drug resistance
- (2012) Hong-Tao Xu et al. Retrovirology
- Low prevalence of transmitted K65R and other tenofovir resistance mutations across different HIV-1 subtypes: implications for pre-exposure prophylaxis
- (2012) Philip A Chan et al. Journal of the International AIDS Society
- Prevalence of low-level HIV-1 variants with reverse transcriptase mutation K65R and the effect of antiretroviral drug exposure on variant levels
- (2011) Michael J Kozal et al. ANTIVIRAL THERAPY
- Detection of Low-Level K65R Variants in Nucleoside Reverse Transcriptase Inhibitor–Naive Chronic and Acute HIV-1 Subtype C Infections
- (2011) Jin-fen Li et al. JOURNAL OF INFECTIOUS DISEASES
- K70Q Adds High-Level Tenofovir Resistance to “Q151M Complex” HIV Reverse Transcriptase through the Enhanced Discrimination Mechanism
- (2011) Atsuko Hachiya et al. PLoS One
- A Template-Dependent Dislocation Mechanism Potentiates K65R Reverse Transcriptase Mutation Development in Subtype C Variants of HIV-1
- (2011) Dimitrios Coutsinos et al. PLoS One
- K65R and K65A Substitutions in HIV-1 Reverse Transcriptase Enhance Polymerase Fidelity by Decreasing Both dNTP Misinsertion and Mispaired Primer Extension Efficiencies
- (2010) Scott J. Garforth et al. JOURNAL OF MOLECULAR BIOLOGY
- Tracking a century of global expansion and evolution of HIV to drive understanding and to combat disease
- (2010) Denis M Tebit et al. LANCET INFECTIOUS DISEASES
- Structural basis of HIV-1 resistance to AZT by excision
- (2010) Xiongying Tu et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy
- (2009) Mina C Hosseinipour et al. AIDS
- The A62V and S68G Mutations in HIV-1 Reverse Transcriptase Partially Restore the Replication Defect Associated With the K65R Mutation
- (2009) Evguenia S Svarovskaia et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Structural Basis for the Role of the K65R Mutation in HIV-1 Reverse Transcriptase Polymerization, Excision Antagonism, and Tenofovir Resistance
- (2009) Kalyan Das et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Signature Nucleotide Polymorphisms at Positions 64 and 65 in Reverse Transcriptase Favor the Selection of the K65R Resistance Mutation in HIV‐1 Subtype C
- (2009) Cédric F. Invernizzi et al. JOURNAL OF INFECTIOUS DISEASES
- Prevalence and risk factors for developing K65R mutations among HIV-1 infected patients who fail an initial regimen of fixed-dose combination of stavudine, lamivudine, and nevirapine
- (2008) Somnuek Sungkanuparph et al. JOURNAL OF CLINICAL VIROLOGY
- Utilization of a Deoxynucleoside Diphosphate Substrate by HIV Reverse Transcriptase
- (2008) Scott J. Garforth et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started